The role of leptin and its short-form receptor in inflammation in db/db mice infused with peritoneal dialysis fluid

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3119-3129

  Leung, Joseph C K ^a   Chan, Loretta Y Y ^a   Lam, Man Fai ^a   Tang, Sydney C W ^a   Chow, Chui Wa ^a   Lim, Ai Ing ^a   Lai, Kar Neng ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

adipocyte; db db mice; leptin; leptin receptor; TNF

Indexed keywords

ADIPONECTIN; ALBUMIN; CREATININE; DIANEAL; INTERLEUKIN 6; LEPTIN; LEPTIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PERITONEAL DIALYSIS FLUID; RINGER LACTATE SOLUTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPONECTIN GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; CYTOKINE PRODUCTION; GENE; GENE EXPRESSION REGULATION; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HYPERLEPTINEMIA; INTERLEUKIN 6 GENE; INTRAABDOMINAL FAT; LEPTIN GENE; LEPTIN RECEPTOR GENE; MALE; MOLECULAR PATHOLOGY; MONOCYTE CHEMOTACTIC PROTEIN 1 GENE; MOUSE; NONHUMAN; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA GENE; TUMOR NECROSIS FACTOR ALPHA GENE; UPREGULATION; UREMIA; VASCULOTROPIN GENE;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; DIABETES MELLITUS; DIALYSIS SOLUTIONS; DNA PRIMERS; INFLAMMATION; INTERLEUKIN-6; LEPTIN; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RECEPTORS, LEPTIN; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84864606642     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr774     Document Type: Article

References (48)

1. Lai KN, Leung JC. Peritoneal adipocytes and their role in inflammation during peritoneal dialysis. Mediators Inflamm 2010; 2010: 495416..
2. Mendelssohn DC. PD and the future: the role of PD in the overall management of ESRD. Blood Purif 2003; 21: 24-28.
3. Di Paolo N, Sacchi G, De Mia M et al. Morphology of the peritoneal membrane during continuous ambulatory peritoneal dialysis. Nephron 1986; 44: 204-211.
4. Mateijsen MA, van der Wal AC, Hendriks PM et al. Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 1999; 19: 517-525.
5. Topley N, Jorres A, Luttmann Wet al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha. Kidney Int 1993; 43: 226-233.
6. Skoufos L, Topley N, Cooker L et al. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactatebuffered peritoneal dialysis fluid. Kidney Int Suppl 2003; 88: S94-S99.
7. Lai KN, Leung JC. Inflammation in peritoneal dialysis. Nephron Clin Pract 2010; 116: c11-c18.
8. Wolf G, Chen S, Han DC et al. Leptin and renal disease. Am J Kidney Dis 2002; 39: 1-11.
9. Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 17-30.
10. Tsujimoto Y, Shoji T, Tabata T et al. Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1999; 34: 832-838.
11. Tartaglia LA. The leptin receptor. J Biol Chem 1997; 272: 6093-6096.
12. Ahima RS, Osei SY. Leptin signaling. Physiol Behav 2004; 81: 223-241.
13. Myers MG, Jr. Leptin receptor signaling and the regulation of mammalian physiology. Recent Prog Horm Res 2004; 59: 287-304.
14. Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006; 393 (Pt 1): 7-20.
15. Hegyi K, Fulop K, Kovacs K et al. Leptin-induced signal transduction pathways. Cell Biol Int 2004; 28: 159-169.
16. Murakami T, Yamashita T, Iida M et al. A short form of leptin receptor performs signal transduction. Biochem Biophys Res Commun 1997; 231: 26-29.
17. Vaisse C, Halaas JL, Horvath CM et al. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat Genet 1996; 14: 95-97.
18. Tang SC, Chan LY, Leung JC et al. Additive renoprotective effects of B2-kinin receptor blocker and PPAR-gamma agonist in uninephrectomized db/db mice. Lab Invest 2011; 91: 1351-1362.
19. Hauner H, Entenmann G, Wabitsch M et al. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest 1989; 84: 1663-1670.
20. Teta D, Tedjani A, Burnier M et al. Glucose-containing peritoneal dialysis fluids regulate leptin secretion from 3T3-L1 adipocytes. Nephrol Dial Transplant 2005; 20: 1329-1335.
21. Teta D, Bevington A, Brown J et al. Effects of acidosis on leptin secretion from 3T3-L1 adipocytes and on serum leptin in the uraemic rat. Clin Sci (Lond) 1999; 97: 363-368.
22. Teta D, Maillard M, Tedjani A et al. The effect of pH-neutral peritoneal dialysis fluids on adipokine secretion from cultured adipocytes. Nephrol Dial Transplant 2007; 22: 862-869.
23. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280: E827-E847.
24. Kim DJ, Oh DJ, Kim B et al. The effect of continuous ambulatory peritoneal dialysis on change in serum leptin. Perit Dial Int 1999; 19 (Suppl 2): S172-S175.
25. Stenvinkel P, Lindholm B, Lonnqvist F et al. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol 2000; 11: 1303-1309.
26. Lam MF, Leung JC, Lo WK et al. Hyperleptinaemia and chronic inflammation after peritonitis predicts poor nutritional status and mortality in patients on peritoneal dialysis. Nephrol Dial Transplant 2007; 22: 1445-1450.
27. Zarkesh-Esfahani H, Pockley G, Metcalfe RA et al. High-dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 2001; 167: 4593-4599.
28. Gomez R, Scotece M, Conde J et al. Adiponectin and leptin increase IL-8 production in human chondrocytes. Ann Rheum Dis 2011
29. Leung JC, Chan LY, Tang SC et al. Leptin induces TGF-beta synthesis through functional leptin receptor expressed by human peritoneal mesothelial cell. Kidney Int 2006; 69: 2078-2086.
30. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
31. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
32. Axelsson J, Rashid Qureshi A, Suliman ME et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-1229.
33. Banks AS, Davis SM, Bates SH et al. Activation of downstream signals by the long form of the leptin receptor. J Biol Chem 2000; 275: 14563-14572.
34. Bjorbaek C, Uotani S, da Silva B et al. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 1997; 272: 32686-32695.
35. Hekerman P, Zeidler J, Bamberg-Lemper S et al. Pleiotropy of leptin receptor signalling is defined by distinct roles of the intracellular tyrosines. FEBS J 2005; 272: 109-119.
36. Morris DL, Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab 2009; 297: E1247-E1259.
37. Li C, Friedman JM. Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction. Proc Natl Acad Sci U S A 1999; 96: 9677-9682.
38. Hileman SM, Tornoe J, Flier JS et al. Transcellular transport of leptin by the short leptin receptor isoform ObRa in Madin-Darby Canine Kidney cells. Endocrinology 2000; 141: 1955-1961.
39. Kastin AJ, Pan W, Maness LM et al. Decreased transport of leptin across the blood-brain barrier in rats lacking the short form of the leptin receptor. Peptides 1999; 20: 1449-1453.
40. Han DC, Isono M, Chen S et al. Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 2001; 59: 1315-1323.
41. Hosoi T, Okuma Y, Nomura Y. Leptin regulates interleukin-1beta expression in the brain via the STAT3-independent mechanisms. Brain Res 2002; 949: 139-146.
42. Zhao AZ, Shinohara MM, Huang D et al. Leptin induces insulinlike signaling that antagonizes cAMP elevation by glucagon in hepatocytes. J Biol Chem 2000; 275: 11348-11354.
43. Brabant G, Muller G, Horn R et al. Hepatic leptin signaling in obesity. FASEB J 2005; 19: 1048-1050.
44. Tan BK, Chen J, Brown J et al. In vivo and ex vivo regulation of visfatin production by leptin in human and murine adipose tissue: role of mitogen-activated protein kinase and phosphatidylinositol 3- kinase signaling pathways. Endocrinology 2009; 150: 3530-3539.
45. Sahai A, Malladi P, Pan X et al. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1035-G1043.
46. Le D, Marks D, Lyle E et al. Serum leptin levels, hepatic leptin receptor transcription, and clinical predictors of non-alcoholic steatohepatitis in obese bariatric surgery patients. Surg Endosc 2007; 21: 1593-1599.
47. McIntyre CW. Update on peritoneal dialysis solutions. Kidney Int 2007; 71: 486-490.
48. ter Wee PM, van Ittersum FJ. The new peritoneal dialysis solutions: friends only, or foes in part?. Nat Clin Pract Nephrol 2007; 3: 604-612